Rothschild & CO Asset Management Us Inc. Danaher Corp Transaction History

Rothschild & CO Asset Management Us Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$133.47 - $153.48 $29.8 Million - $34.3 Million	-223,549 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$135.4 - $146.47 $583,167 - $630,846	-4,307 Reduced 1.89%	223,549 $32.3 Million
Q2 2019 Jul 25, 2019	BUY	$124.88 - $143.73 $336,801 - $387,639	2,697 Added 1.2%	227,856 $32.6 Million
Q1 2019 May 08, 2019	SELL	$97.62 - $132.29 $263,964 - $357,712	-2,704 Reduced 1.19%	225,159 $29.7 Million
Q4 2018 Feb 05, 2019	BUY	$94.85 - $109.54 $226,786 - $261,910	2,391 Added 1.06%	227,863 $23.5 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $1.2 Million - $1.33 Million	12,182 Added 5.71%	225,472 $24.5 Million
Q2 2018 Aug 07, 2018	SELL	$96.1 - $103.24 $12.4 Million - $13.3 Million	-129,161 Reduced 37.72%	213,290 $21 Million
Q1 2018 May 08, 2018	SELL	$92.16 - $103.8 $16.1 Million - $18.1 Million	-174,442 Reduced 33.75%	342,451 $33.5 Million
Q4 2017 Feb 12, 2018	SELL	$85.26 - $94.62 $1.3 Million - $1.44 Million	-15,196 Reduced 2.86%	516,893 $48 Million
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $42.2 Million - $47.1 Million	532,089	532,089 $45.6 Million

2,509

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.